U.S. Insurance Stock News

Why a proposed class action settlement matters for Oppenheimer Holdings Oppenheimer Holdings (OPY) is back in focus after Oppenheimer & Co. Inc. agreed to a proposed US$70,000,000 settlement in a class action lawsuit, with court approval scheduled to be considered in September 2026. See our latest analysis for Oppenheimer Holdings. The proposed settlement arrives at a time when Oppenheimer Holdings has seen a 30-day share price return of 15.13% and a year-to-date share price return of 45.29%...

Hinge Health (NYSE:HNGE) has been added to multiple major Russell indexes following its latest quarterly results. The index changes coincide with the company reporting strong quarterly performance. Hinge Health also raised its full year guidance around the same time as the Russell index inclusions. The combination of broader index exposure and updated outlook marks a key moment for the company’s public market profile. Hinge Health focuses on digital musculoskeletal care, an area that sits...

Index reshuffle puts fresh attention on nCino stock nCino (NCNO) is back in focus after a broad reshuffle of its index memberships, with the stock added to several Russell 2000 segments while being removed from multiple Russell 1000 and Midcap benchmarks. These shifts typically prompt passive index trackers to rebalance their holdings, which can influence trading volumes around the effective date and encourage active investors to reassess how nCino fits within small cap, growth, and value...

AI infrastructure has shifted from a niche theme to a major force in markets, as investors respond to headlines about Micron, Intel, AMD and other chip stocks adding trillions in combined market value. Instead of chasing every hype cycle, it can help to focus on companies with solid financial and market metrics that are directly exposed to this AI infrastructure build out. This article walks through 3 stocks from our AI Infrastructure Beneficiaries screener that appear positively exposed to...

Urban Outfitters (URBN) has been removed from the Russell 2000 Dynamic Index, a shift that can influence how index-tracking funds treat the stock and potentially affect short term trading flows. See our latest analysis for Urban Outfitters. At a share price of US$70.86, Urban Outfitters has seen short term share price pressure, with the 30 day share price return down 2.46%, while the 90 day share price return is up 11.21% and the 3 year total shareholder return is 110.14%. This points to...

Interest rate headlines are back in focus as the Federal Reserve signals a possible pause or slowdown in hikes, and that matters for rate sensitive areas like Real Estate and Utilities. With mixed economic data and a cautious central bank, some stocks in these sectors may see sentiment shift as investors rethink income, value, and balance sheet risk. This article looks at 3 stocks from a Rate Sensitive Sectors screener that appear positively exposed to the current Fed stance. It is intended...

Following a 23% one day jump after its latest earnings release, Twilio (TWLO) has seen its share price cool, creating fresh interest among investors who are assessing whether this reset offers a more measured entry. See our latest analysis for Twilio. That sharp earnings gap and subsequent cool off sit within a wider upswing for Twilio, with a 90 day share price return of 58.16% and a 1 year total shareholder return of 76.00%. This indicates momentum that has recently been strong rather than...

In late June 2026, Loar Holdings Inc. (NYSE: LOAR) was removed from several Russell growth indices, including the Russell 1000 Growth, Russell 3000 Growth, Russell 3000E Growth, Russell Midcap Growth, and Russell 2500 Growth benchmarks, prompting benchmark-driven portfolio rebalancing. This broad index removal contrasts with ongoing positive analyst views and hedge fund interest, highlighting how benchmark membership can materially influence investor demand and company visibility. Next,...

Cytokinetics reported progress in turning its lead heart drug Myqorzo from a development program into an early commercial product, supported by prior regulatory approvals in the US, Europe, and China. Early physician adoption and patient response, together with Myqorzo’s differentiated mechanism in obstructive hypertrophic cardiomyopathy, are sharpening expectations around its broader clinical and competitive role. Next, we’ll look at how Myqorzo’s early commercial uptake and multi-region...

Whirlpool stock performance snapshot Whirlpool (WHR) stock has been under pressure recently, with the share price around $39.42 and total returns declining over the past month, past 3 months, year to date, and the past 1 year. See our latest analysis for Whirlpool. For Whirlpool, the recent 1 week share price return of 8.93% comes after a tougher stretch, with the 30 day share price return down 9.21% and the 1 year total shareholder return down 61.20%. This suggests recent momentum is...

Why Arlo Technologies Stock Is Back in Focus Arlo Technologies (ARLO) is drawing fresh attention after announcing an expanded partnership that brings Aloe Care Health’s new ConnectAI wellness calling solution into Home Helpers Home Care’s in-home care offerings for aging clients. The move deepens Arlo Technologies’ role in AI-powered, connected care by linking smart home capabilities with proactive wellness check-ins, medication reminders, and care insights for people who want to remain...

What SiTime’s Index Moves Mean for Investors SiTime (SITM) has shifted into a new tier of equity benchmarks, joining the Russell 1000, Russell Midcap, and related growth and dynamic indexes while exiting several Russell 2000 variants. For you as an investor, these index changes matter because funds that track the Russell 1000, Russell Midcap, and associated growth benchmarks often adjust their holdings to match the new compositions. That process can influence trading activity in SiTime stock...

In late June 2026, Olema Pharmaceuticals, Inc. (NasdaqGS:OLMA) was added to multiple Russell Growth Benchmarks, including the Russell 2000, 2500, 3000, 3000E, Small Cap Comp, and Microcap Growth indices. This broad index inclusion brings Olema onto the radar of a wide range of index-tracking funds and quantitative investors, potentially changing how the company is positioned in many portfolios. Next, we will examine how Olema’s broad Russell Growth index inclusion shapes its investment...

UFP Technologies (UFPT) has been removed from the Russell 2000 Dynamic Index, a shift that can prompt rebalancing by index-tracking funds and influence how some investors view the stock’s role in diversified portfolios. See our latest analysis for UFP Technologies. The index removal comes after a period of strong momentum for UFP Technologies, with a 30-day share price return of 19.78% and a 90-day share price return of 36.17%. The 5-year total shareholder return of 356.66% points to a very...

Earlier in 2026, Evercore ISI initiated coverage of PROCEPT BioRobotics with an “Outperform” rating, as the company reported completing enrollment in its WATER IV RP randomized prostate cancer trial and securing FDA approval for the WATER IV AS study. These prostate cancer milestones suggest Aquablation therapy could move beyond benign prostatic hyperplasia into a broader urologic oncology role, drawing fresh analyst attention to PROCEPT’s growth pathway. We’ll now examine how progress in...

With UK GDP slipping 0.1% in April and inflation risks back in focus, many investors are rethinking how much economic stress their portfolios can handle. Consumer staples stocks, which sell everyday essentials, can sometimes offer a steadier ride when growth cools and headlines turn harsher. This article looks at how the latest UK data, conflict in Iran and Bank of England inflation warnings could affect large, defensive companies in this space. Ahead, you will see 3 stocks from our Consumer...

In the past week, Concentrix Corporation reported second-quarter 2026 results showing revenue of US$2,462.47 million and net income of US$55.28 million, alongside updated guidance that points to minimal constant-currency revenue growth for the third quarter and full fiscal year. Despite meeting revenue expectations and achieving record iX Suite contract signings with very large year-on-year growth, Concentrix reduced its full-year outlook while affirming its dividend and completing a...

Vornado Realty Trust (VNO) recently triggered investor attention after its 50-day moving average crossed above its 200-day moving average. This golden cross coincided with upward revisions to earnings estimates and renewed interest in the stock. See our latest analysis for Vornado Realty Trust. Recent trading has been strong for Vornado Realty Trust, with a 30-day share price return of 17.07% and a 90-day share price return of 52.02%, suggesting building momentum on top of a 3-year total...

Index removal puts fresh attention on Encompass Health Encompass Health (EHC) has been removed from the Russell 1000 Dynamic Index, an event that can trigger portfolio adjustments by index-linked funds and spur short term trading and price swings for the stock. See our latest analysis for Encompass Health. Over the past year Encompass Health’s share price has seen mixed momentum, with a 7 day share price return of 2.25% and a 90 day share price return of 4.31%. The 1 year total shareholder...

Sarepta Therapeutics (SRPT) is back in focus after the FDA accepted supplemental New Drug Applications for AMONDYS 45 and VYONDYS 53, a regulatory update that could influence how investors assess the stock. See our latest analysis for Sarepta Therapeutics. The FDA sNDA news comes after a weak stretch for Sarepta Therapeutics, with the share price down 21.78% over 90 days and the 3 year total shareholder return declining 85%. This indicates fading momentum despite the regulatory progress. If...

Why Vor Biopharma’s index additions matter for investors Vor Biopharma (VOR) has just been added to a wide range of Russell indexes, including the Russell 2000 and Russell 3000 families, drawing fresh attention from investors and index tracking funds. This kind of broad index inclusion often prompts passive institutional buying activity, which can influence liquidity and trading volumes in the stock. For you as an investor, the key questions are how meaningful this index presence might be and...

Amazon Web Services is putting US$1 billion behind a new Forward Deployed Engineering unit, embedding AI specialists directly inside customer teams. For investors, that kind of spending can reshape how money flows across artificial intelligence and cloud infrastructure, opening up new demand for some companies while leaving others on the sidelines. This article focuses on 3 stocks from our AI and Cloud Infrastructure screener that appear closely exposed to this AWS push, all on the positive...

Earlier this week, Bell Global Equities Fund disclosed that it had added TE Connectivity to its portfolio, citing the company’s leadership in connectors and sensors for electric vehicles, factory automation, and AI-focused data centers, along with its recent dividend increase and expanded share repurchase program. The fund’s move highlights how TE Connectivity’s role in the hardware behind AI data-center buildouts and industrial electrification is increasingly being recognized as a core...

Under Armour (UAA) stock has been in focus after a disappointing quarter with missed full year guidance. However, a 4.4% share price gain and sweeping Russell index reclassifications have reshaped how investors are viewing the company. See our latest analysis for Under Armour. Under Armour’s 7 day share price return of 4.74% and 30 day share price return of 5.45% suggest short term momentum is building. However, the 1 year total shareholder return is down 9.37% and the 5 year total...